Sherbel Sussan - Concepedia

Author

Sherbel Sussan

Hebrew University of Jerusalem

Also Known As

S Sussan, S. Sussan, Sherbel Sussan

Publications

113

Citations

H-Index

Concepts

All Affiliations

Hebrew University of Jerusalem Migal - Galilee Technology Center Carmel Medical Center Technion – Israel Institute of Technology University of Haifa

About

Sherbel Sussan is an author at Hebrew University of Jerusalem specializing in medicine, pharmacology, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	108
2	Engineering	1	1	11
3	Natural Sciences	1	1	11
4	Biochemistry	1	1	11
5	Biomedical Engineering	1	1	11

Sherbel Sussan

Publications

108

Citations

H-Index

Page 1

	Year	Citations
Inhibition of TNFα-induced iNOS expression in HSV-tk transduced 9L glioblastoma cell lines by Marasmius oreades substances through NF-κB- and MAPK-dependent mechanisms Nili Ruimi, R. Petrova, Riad Agbaria, Molecular Biology Reports Signal TransductionSignaling PathwayGliomaMedicineTnfα-induced Inos Expression	2010	23
Existing and new criteria for bioequivalence evaluation of new controlled release (CR) products of carbamazepine Meir Bialer, Lidia Arcavi, Sherbel Sussan, Epilepsy Research Pharmaceutical SciencePharmacological StudyMedicinePharmacotherapyNew Criteria	1998	21
Marasmius oreades substances block NF-κB activity through interference with IKK activation pathway R. Petrova, Jamal Mahajna, Solomon P. Wasser, Molecular Biology Reports InflammationMolecular PharmacologyNf-κb ActivityMolecular PhysiologySignal Transduction	2008	16
Comparative pharmacokinetic and pharmacodynamic analysis of phthaloyl glycine derivatives with potential antiepileptic activity. Omar Abu Salach, Salim Hadad, Abdullah Haj‐Yehia, Pharmaceutical Research Pharmaceutical SciencePharmacological StudyMedicinePotential Antiepileptic ActivityPhthaloyl Glycine Derivatives	1994	16
Oleic acid is the active component in the mushroom Daedalea gibbosa inhibiting Bcr-Abl kinase autophosphorylation activity. Hazem Khamaisie, Sherbel Sussan, Michael Tal, PubMed Selective Kinase InhibitorsMixed-phenotype Acute LeukemiaTumor BiologyMyeloid NeoplasiaHematological Malignancy	2011	11
Criteria To Assess in Vivo Performance of Sustained Release Products: Application to Diltiazem Formulations Meir Bialer, Sherbel Sussan, Omar Abu Salach, Journal of Pharmaceutical Sciences Regenerative MedicineTissue EngineeringEngineeringMedicineTopical Drug	1995	11
Pharmacokinetic analysis and anticonvulsant activity of glycine and glycinamide derivatives Sherbel Sussan, Arie Dagan, Meir Bialer Epilepsy Research Molecular PharmacologyMedicineGlycobiologyNeuropharmacologyClinical Pharmacology	1999	10

Page 1